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Abstract
Background: A large-scale epidemiological study of 6088 individuals with CF and 4102 caregivers in 9 
countries documented elevated symptoms of depression and anxiety, leading to international guidelines 
for annual screening and follow-up. To facilitate national implementation, 84 CF programs funded a 
mental health coordinators (MHC). Implementation was evaluated after 1 year using the Consolidated 
Framework for Implementation Research (CFIR) to identify facilitators and barriers.
Methods: A 45-item internet survey was developed to assess relevant CFIR implementation steps. 
Surveys were completed in 2016. It assessed five domains tailored to study aims: 1) Intervention 
Characteristics, 2) Outer Setting, 3) Inner Setting, 4) Characteristics of Individuals, and 5) Process of 
Implementation.
Results:  Response rate was 88%, with pediatric and adult programs equally represented. A majority of 
MHCs were social workers (54.1%) and psychologists (41.9%); 41% had joined the team in the past year. 
Facilitators across the 5 domains included universal uptake of screening tools, greater awareness and 
detection of psychological symptoms, reduced stigma, and positive feedback from patients and families. 
Barriers included limited staff time, space, and logistics. 
Discussion: This is the largest systematic effort to integrate mental health screening and treatment into the 
care of individuals with a serious, chronic illness and their caregivers. MHCs implementing screening, 
interpretation and follow-up reported positive results, and significant barriers. This national 
implementation effort demonstrated that depression and anxiety can be efficiently evaluated and treated in 
a complex, chronic disease. Future efforts include recommending the addition of screening scores to 
national CF Registries and examining their effects on health outcomes. 
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Introduction
A large-scale epidemiological study of the prevalence of depression and anxiety in individuals 
with cystic fibrosis (CF) and parent caregivers provided clear evidence of elevated risk1. Across nine 
countries, 17% of the 6088 patients, ages 12 through adulthood, reported elevated symptoms of 
depression and 30% reported elevated symptoms of anxiety (TIDES study; The International 
Depression/Anxiety Epidemiological Study1). Rates of depression and anxiety among the 4102 parent 
caregivers ranged from 31-48%.  Across respondents, rates of depression and anxiety were two to three 
times higher than community samples2-4. High comorbidity of these psychological symptoms was also 
documented across 1122 parent-teen dyads, with adolescents more than twice as likely to report elevated 
symptoms of depression or anxiety if either parent was elevated, indicating that a family systems 
approach to addressing mental health is needed.  
Depression and anxiety are a major concern because they are strongly associated with negative 
health consequences and outcomes: worse adherence5-12, worse pulmonary function and body mass 
index8, 13, 14, decreased health-related quality of life6, 7, and increased hospitalizations and healthcare 
costs14. Depression was associated with a higher risk of mortality within 5 years15. Further, new studies in 
other chronic conditions suggest that depression, independent of disease, is associated with 
inflammation16. Given that inflammation in CF has been linked to recurring pulmonary exacerbations, 
which are associated with greater morbidity and earlier mortality16, addressing mental health issues may 
be an important pathway to improving health and extending lifespan in CF.
The TIDES study was the major impetus for integrating mental health into the specialized medical 
care for people with CF, given that rates of depression and anxiety were 2-3 times higher than those found 
in community samples1.  Thus, these results led the Cystic Fibrosis Foundation (CFF) and the European 
Cystic Fibrosis Society (ECFS) to form an International Committee on Mental Health in CF (ICMH). A 
representative, multidisciplinary group of CF experts (including a person with CF, two caregivers) met for 
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two years to develop guidelines for the screening and treatment of depression and anxiety in both 
individuals with CF and parent caregivers17. The ICMH’s recommendations included standardized 
screening instruments, follow-up, and evidence-based recommendations for psychological and 
pharmacological treatments. Although depression screening has been recommended by other national 
associations (e.g., American Diabetes Association18, American Academy of Pediatrics19), few of these 
guidelines have been implemented20, and none have recommended screening both adolescents with a 
chronic illness and their caregivers. A systematic review examining evidence on improving the quality of 
mental health care delivery identified a dearth of studies that were successful with this integration and 
organizational change21. 
To facilitate implementation of these guidelines, a competitive grant process was initiated by the 
CFF to fund a Mental Health Coordinator (MHC) for 3 years, with a primary role of initiating screening 
according to the guidelines, coordinating follow-up, and tracking outcomes across 84 CF programs. 
Grants were peer-reviewed by a 15-member multidisciplinary committee. All CFF-accredited Care 
Center, Programs and Affiliates were eligible to apply (n= 277). CFF received 154 grant proposals which 
were judged on the following criteria: 1) Current progress in implementing mental health screening in 
their clinic; 2) Plans to implement screening and treatment; 3) Plans to make referrals for mental health 
services in their hospital and community; 4) Plans to provide psychological support and interventions as 
needed; and 5) Plan for sustainability. We were not able to include CF Centers in other countries. 
However, a number of international implementation efforts were undertaken once the guidelines were 
implemented in Year 1. A member of the CFF Mental Health Advisory Committee serves as a liaison to 
the European Cystic Fibrosis Society to facilitate dissemination of the guidelines in Europe, another 
member of this committee trained 10 CF Centers in Canada, and two committee members launched a 
“Mental Health Roadshow” across Australia.
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To evaluate the success of this implementation effort, the Consolidated Framework for 
Implementation Research22 (CFIR) was utilized and customized to reflect the new psychological 
screening and treatment guidelines.  CFIR is the most widely used conceptual framework, with over 300 
published articles, which assesses stakeholder’s perceptions of the benefits of a new intervention 
strategies (i.e., mental health screening of people with CF and caregivers), as well as the key facilitators 
and barriers of intervention success. Thus, it was designed to lead to iterative improvements in delivery of 
a new healthcare intervention over time. 
Although the CFIR model is considered the “gold standard” framework for evaluating 
implementation of new practice guidelines, it is complex and cumbersome, and requires tailoring of the 
key variables to the specific context23. Five primary domains were modeled: 1) Intervention 
Characteristics, 2) Outer Setting, 3) Inner Setting, 4) Characteristics of Individuals, and 5) Process of 
Implementation (see Figure 1). 
To evaluate implementation success, we tailored the five CFIR domains to the aims of the 
published mental health guidelines and defined each implementation construct and its relevant facilitators 
and barriers (see Table 1). The first domain, Intervention Characteristics, is characterized by 
implementation of annual mental health screening, provision of brief interventions in clinic, and referrals 
into the community. The second domain, Outer Setting, includes evidence-based guidelines, CFF 
resources and national conference, widespread adoption of the guidelines. The third domain, Inner 
Setting, is exemplified by CF team culture, training in quality improvement, CF Center Director and CFF 
Executive Leadership. The fourth domain, Characteristics of individuals, includes professional training 
of MHC, years of experience in CF care, and individual training opportunities at the North American 
Cystic Fibrosis Conference (NACFC). The final domain, Process of Implementation, is embodied by 
identification of the MHC champion, involvement of stakeholders on the team, and plan for execution of 
annual screening and follow-up. Thus, the major aim of this study was to apply the CFIR constructs 
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defined above to evaluate the implementation of standardized screening of depression and anxiety among 




CFF administered the internet survey (via SurveyMonkey) to the first 84 CF pediatric and adult programs 
that received the award, with a start-date of January, 2016. The survey was emailed to the principal 
investigator (i.e., Center Director) and distributed on September 7th 2016, with reminders sent November 
3, 10 and December 2.  Thus, many programs had less than one year of implementation experience.
Measure                                                                                                                                                                                                       
 The survey was developed by the CFF-sponsored Mental Health Advisory Committee (MHAC), a 
multidisciplinary research subcommittee comprised of health care professionals (e.g., pulmonologists, 
psychologists, psychiatrists, adult with CF) with strong interests in advancing integration of mental health 
into CF care. Seven US and one UK member developed the survey. An iterative, consensus-based process 
was used to create the 45-items (see online supplement), organized into the five CFIR domains described 
above.  Most responses were ‘check boxes’ or required numerical data (e.g. characteristics of center, 
screening outcomes), with 1 open-ended question on major successes.
Data analysis                                                                                                                                                                                                                                                           
Data were analyzed using SPSS version 24.  Multiple response frequencies and the mean rank 
order of items were determined. Text responses were analyzed thematically and a rigorous method of 
coding the text was devised24.  Line by line coding of the transcripts was undertaken, with codes attached 
to specific words, phrases, or sentences. These codes were then grouped into conceptual categories, based 
on emerging themes (coherent, meaningful patterns in the data). This was done independently by two 
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researchers (JA, LV) to ensure that comparable interpretations were being made. When discrepancies 
were found, they were discussed and resolved through consensus. 
Results
There were 74 respondents, yielding a response rate of 88%. Not all programs had hired or 
integrated an MHC into their program when the survey was deployed.  Table 2 reflects aspects of the 
Inner Setting and Characteristics of the Individuals. A majority of programs employed a social worker (40 
of 74 programs, 54.1%) or psychologist (41.9%) to perform mental health screening and follow-up. 
Approximately half of these professionals were newly employed or had been integrated into the CF team 
for less than 1 year (38 of 74 programs, 51%).  We were not able to document when and how these 
positions were filled; grants were awarded at the same time, but the contracting process often varied 
across hospitals and medical centers.
1) Screening process and use of the recommended screening tools 
Results of the screening process are presented in Table 3 and focused on questions related to the 
processes of implementation. This table, which reports the percentage of MHCs who endorsed items on:  
1) preparedness for screening patients and caregivers; 2) ease of administering, scoring and interpreting 
the screening scores; 3) MHC observations of patient and caregiver perceptions of screening and 4) MHC 
training and ability to provide follow-up and referrals.  These results reflect both Intervention 
Characteristics and Process of Implementation. 
2) Successes and barriers to implementation
The emerging themes concerning ‘successes’ are highlighted in Table 4. They demonstrate: 1) 
greater awareness, detection and management of MH issues by CF professionals, “prevention and early 
identification before major mental health concerns arise,” 2) reductions in stigma and willingness to 
discuss MH issues, “increased normalization of mental health concerns in CF,” and 3) gratitude and 
support from families / patients for addressing MH, “most families are very excited about this and find 
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mental health a much needed addition in the clinic.” MHCs reported that numerous patients and 
caregivers expressed their appreciation that MH is being measured and addressed, and they noted their 
increased understanding of ‘treatment’ options available for MH problems. These results reflect 
Intervention Characteristics, Outer Setting, and Inner Setting. 
Respondents were asked to rank a list of nine potential barriers to screening (from most to least 
significant). The ‘top’ barriers across respondents were: 1) limited staff time (53%), space limitations 
(47%), perceived patient burden (42%) and logistics e.g., storing data (42%). A sub-analysis compared 
the perceived barriers reported by social workers vs. psychologists/psychiatrists and found that social 
workers ranked “patient burden” as the top barrier, whereas psychologists/psychiatrists ranked “limited 
staffing” as the top barrier, with “patient burden” ranked 4th. Additionally, data generated from the 
thematic analysis highlighted the main barriers/ethical dilemmas faced by MHCs (Table 5): 1) the ‘ethical 
and legal’ aspects of screening adult caregivers in a pediatric department and storage of caregiver data and 
2) difficulty with logistics, follow-up and referrals.  Additional resources rated as most helpful were: 1) 
more mental health staff, in particular psychiatrists, and 2) support outside the clinic, e.g. community 
providers. These results reflect both Intervention Characteristics and Inner Setting. 
3) Patient and caregiver perceptions and outcomes
Programs reported variable start times for initiating screening. Some programs had already begun 
setting up these processes and others had started only a few months prior to the survey. Approximately 
5000 individuals and over 1000 caregivers were screened. Numerical results of individual patients per 
program were not obtained given the quality improvement focus of this survey.  Suicidal ideation was 
endorsed by 141 patients and 15 caregivers. Figure 2 provides the data on referrals and interventions. This 
reflects the Process of Implementation and Intervention Characteristics.  
4) Needs assessment focused on additional education and training for MHCs.
Page 8 of 30Pediatric Pulmonology
9
Only 2 programs reported they did not have a team member trained in MH counseling interventions. 
Respondents reported participating in: training in MH screening (91.9%), cognitive behavioral therapy 
(85.1%), counselling or supportive therapy (94.6%) and prescribing medications for depression/anxiety 
(44.6%). A sub-analysis compared providers’ perceptions of how adequately trained they were in 
counselling those scoring in the mild range: 60% of social workers rated their training as “adequate,” 
whereas 91% of psychologists/psychiatrists rated it as “adequate,” X2 (3, N = 77) = 12.42, p <.01). For 
those scoring in the moderate to severe range, only 40% of social workers felt adequately trained to 
provide counselling compared to 88% of psychologists/psychiatrists (X2 (3, N =77) = 18.56, p< .001).  
Chi Square analyses were also utilized to compare responses to the question “How easy has it been to 
implement screening?” for the variables related to length of experience working on a CF Team and 
pediatric vs. adult CF programs. There were no differences in ease of implementation based on years of 
experience on a CF Team (X2(9, n=74)= 7.91, p = .59, ns), We also found no differences in responses to 
this question based on whether the CF program served pediatric or adult patients with CF (e.g., we 
removed CF Centers that care for both populations) (X2 (3, n=51) =3.70, p=.29, ns). The following 
education and training programs were endorsed by respondents: 1) a workshop on the screening process 
(67.6%), 2) access to a MH hotline (60.8%), 3) short course on medications (44.9%), 4) access to a 
mentoring program (44.5%) and 5) short courses on Cognitive Behavioral Therapy (CBT) and 
Interpersonal therapy (36.5%). These results reflect Intervention Characteristics, Process of 
Implementation, and the Outer Setting. 
Discussion
This is the largest systematic effort ever conducted to integrate mental health screening and 
treatment into the care of individuals with a serious, chronic illness and their caregivers. Over 5,000 
individuals with CF and over 1,000 caregivers were screened in one year. Our adaptation of the CFIR 
model was comprised of: 1) an international epidemiological study of the prevalence of depression and 
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anxiety1, 2) a review of the literature by experts in the US and Europe to identify the best screening tools 
and develop evidence-based guidelines for screening and psychological/ pharmacological treatments, 3) 
implementation of a standardized screening and follow-up protocol, and 4) implementation grants 
provided to 84 CF programs in the US.  At the end of Year 1, MHCs completed a survey evaluating both 
the implementation process, its successes, barriers, and their future educational and training needs. Both 
rating scale and qualitative responses were analyzed.
Dissemination and implementation of guidelines have always faced significant challenges, in part 
because changes to health care systems and practices are so complex25. However, with the support of the 
CFF, efforts by the MHAC and strategic planning, we demonstrated positive results in implementing 
these guidelines. The response rate was 88%, which was excellent, given that programs were in the hiring 
or orientation process. The sample was diverse and nationally representative, with programs ranging from 
small to large, located across the US, and similar to programs accredited by CFF. Overwhelmingly 
positive results were found in preparation to conduct mental health screening and use and interpretation of 
the screening tools. Patients and caregivers were perceived as positive about the screening process (over 
95%) and most MHCs rated their training as “somewhat adequate-very adequate.” An unanticipated 
benefit of this implementation effort was the introduction of new mental health professionals (e.g., social 
workers, psychologists, psychiatrists) to the multidisciplinary CF team.  Over half of the MHCs were 
either new to CF or had been working in this area for less than one year, indicating that new professionals 
joined CF programs, resulting in an influx of new talent, energy and ideas. Providers who were new to CF 
Care did not find implementation more difficult than those with many years of CF experience.
One overarching implementation challenge in the Intervention Characteristics domain was 
preparing MHCs to address suicidal ideation if endorsed on the PHQ-9. We recommended training in the 
Columbia Suicide Severity Rating Scale (CSSRS) 26 and use of this assessment tool if question #9 is 
endorsed. The CSSRS has extensive validation data and is used by both healthcare (doctors, nurses) and 
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lay professionals (e.g., policeman, teachers), followed by a clinical interview. Training on the CSSRS 
yielded an online training certificate. Endorsement of this item occurred more frequently than we 
anticipated (results above), which affirmed our decision to include this item in screening. CF Centers 
were also encouraged to develop suicide safety plans that could be activated if needed.
A second implementation challenge, documented in the Inner Setting, was initiating screening for 
caregivers. This recommendation, to screen depression/anxiety in parents of children with CF ages birth 
to 17 years, was controversial given that parents are not the “identified patient.” Although the ICMH had 
empirical data to support this recommendation (i.e., high prevalence of elevated symptoms across over 
4,000 caregivers17), a number of concerns were raised prior to implementation: 1) ethical issues related to 
screening parents, 2) recording and storing their data, and 3) challenges referring caregivers for 
psychological assistance when needed.  Our implementation data shed light on these issues.  Although 
caregivers were very positive about screening (over 95% “somewhat-very positive”); and most MHCs 
were “somewhat” to “very prepared” to screen parents, and follow-up was “somewhat” to “very easy,” 
challenges remained. These included ethical issues about reporting and storing caregiver data, and having 
adequate space to screen adolescents separately from their parents20, 27. In general, MHCs were successful 
in screening parents, which enabled these pediatric programs to take a “family systems” approach to 
managing CF. Given the high rates of depression and anxiety reported by parents5,17 and the importance 
of acknowledging and validating this as a normative response, our implementation effort could serve as a 
model for providing more family-centered care in other pediatric specialty clinics (e.g., diabetes, sickle 
cell, epilepsy).  
The most commonly reported barriers were: limited staff time, space limitations, respondent 
burden, and logistics (e.g., storing data), endorsed by 42%-53.4% of MHCs.  Many of these barriers 
seemed solvable, and establishment of the mental health listserv led to frequent discussions  of
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these barriers and potential solutions1. The MHAC has encouraged processes that increase 
efficiency, such as use of electronic screening (e.g., iPads, tablets) with automatic scoring and storage 
using programs, such as RedCap, which is HIPPA compliant and secure, rather than paper-pencil data 
collection, which requires data entry and storage.  Screening takes 5-8 minutes with the PHQ-9 and GAD-
7, but if scores are elevated, additional time is required to discuss next steps. Solving logistics related to 
space is more difficult. Space is at a premium in most CF clinics, and infection control guidelines for 
people with CF28 recommend immediate placement in an exam room, with disinfection between patients. 
Use of disposable Ziploc bags for screening on iPads or phones has also been widely implemented for 
infection control. The psychosocial listserv is open to everyone, with about 425 participants from 10-12 
countries.  To address training needs, the CFF and MHAC worked together to provide a toolbox and 
Welcome Packet for MH screening2, workshops and short courses at the annual North American Cystic 
Fibrosis Conference (NACFC), and a new, phone-based mentoring program. These links and tools are 
available to everyone.
Implementation of new procedures and quality improvement in any learning health care system 
requires an iterative process to solve emerging barriers and identify the key successes29. The benefits of 
this screening program were significant, including earlier and better identification of mental health 
symptoms, reductions in the stigma related to these symptoms, improved understanding of the behavioral 
health variables that affect disease management and health outcomes (e.g., depression leading to worse 
adherence), and greater collaboration within the multidisciplinary team. Critically important, 
improvements in symptoms of depression and anxiety were observed by MHCs and appropriate 
interventions were provided to the 141 individuals with CF and 15 caregivers who endorsed suicidal 
1 To join the mental health listserv, visit mentalhealth@cff.org
 
3To access training materials, visit mentalhealth@cff.org
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ideation.  There is little data on the prevalence of suicidal ideation or explicit suicide in the CF population, 
but it is likely much higher than realized.
In general, MHCs reported they were prepared and well-trained; 92% attended a training and 85% 
had training in CBT interventions. More training was needed in prescribing anti-depressant medications 
(64%) and MHCs requested access to a mental health hotline and mentoring (44.5%). These training 
needs have been targeted in the NACFC meeting via short courses, symposia and “brown bag” sessions. 
The success of this mental health implementation effort, including nearly universal uptake of screening, is 
also testament to the dedication of CF care teams in integrating mental health into routine care, and their 
recognition of the importance of normalizing and addressing mental health concerns. 
Limitations and Future Directions
This large-scale implementation effort at 84 pediatric and adult CF programs was an ambitious 
project guided by our CFIR model. The CF Foundation provided funding to hire new mental health 
professionals or covered the time of existing staff to conduct screening and follow-up via this competitive 
grant mechanism.  This financial support clearly jump-started the process, however the task now is to 
sustain it when current funding ends. The difficulties of sustaining these system changes underlies every 
new initiative and quality improvement project that seeks to improve the delivery of health care, 
particularly for complex, chronic conditions29.  A number of avenues for sustainability are being explored: 
1) billing for psychological services, 2) financial savings associated with treating mental health concerns, 
potentially reducing the costs of poor adherence, missed clinic visits, and hospitalizations, and 3) 
developing cost-sharing models with hospital administrators.  The Cystic Fibrosis Foundation is 
committed to supporting the integration of mental health into the specialized care provided to people with 
CF and plans to provide additional funding beginning mid-year. Ultimately, sustaining this program will  
require advocacy by those who are affected--individuals with CF, caregivers, and providers serving this 
population—to speak out about the importance of integrating mental health and physical care, and 
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lobbying for continuation of these efforts.  Future research should evaluate the effectiveness of this mental 
health intervention on clinic attendance, adherence, frequency of hospitalizations, health-related quality of 
life, and mortality15. One critical avenue for advancing this process is to recommend inclusion of these 
screening scores in well-established national registries (e.g., UK and US). These data will be critical to the 
sustainability of this implementation model.
Additional limitations of this study should be noted. The survey required self-reported responses, 
and there is always the potential for self-report data to be biased, depending on the perspective of the 
respondent. However, it is critical to evaluate the perceptions of the professionals who are implementing 
the mental health screening protocol. The alternative, collecting observational data, was not feasible in a 
study surveying this large number of CF programs. Given that this was the first year these grants were 
awarded, the initial Year 1 survey may have recorded more positive results, skewed by the novelty of this 
mental health initiative (e.g., a honeymoon period). On the other hand, given the challenges of initiating 
any systematic change in a health care system, the MHCs may have also been experiencing “growing 
pains” as they identified the best processes for conducting screening and brief interventions.
 Further, not all CF programs were funded to initiate screening, and thus, these data do not 
represent all US CF programs. However, 36 additional CF programs were funded in a second request for 
applications, and a 3rd round funded 18 more CF Centers. Furthermore, the CFF has made an additional 
commitment to provide ongoing funding to all CF programs for mental health screening and treatment. 
Given that this study was not focused on collecting and analyzing screening data from patients and 
caregivers, we could not demonstrate that identifying and treating these psychological symptoms made a 
difference in health outcomes. Adding screening data to existing registries would be required for this.
In conclusion, we have shown that it is possible to incorporate mental health screening and 
treatment into busy, specialized clinics that treat a complex, chronic illness that begins at birth and 
continues through adulthood.  Several implementation efforts contributed to this success, including 
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development of a toolkit to help practitioners, a listserv that became an open forum for providers in the 
US and other countries to post questions and offer suggestions, and the incorporation of training sessions 
into the annual CF conference, which built expertise into the national community. This mental health 
screening and treatment program can serve as a model for patient-centered care in other chronic 
conditions, many of which also have a high prevalence of depression and anxiety (e.g., multiple sclerosis, 
epilepsy), that is not currently addressed30, 31. This project has now expanded screening to 138 programs, 
and data are being gathered now to track this implementation process over time.
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Table 1: Application of the CFIR Model to Integration of Mental Health Screening & Treatment in CF Clinics1
Domain Definition Facilitators Barriers
A. Intervention Characteristics
 Implementation of annual 
mental health screening in CF 
Clinics
 Implementation of brief, 
evidence-based intervention in 
Clinics
 Referrals within hospitals or in 
community
 Follow-up of elevated scores
 Dissemination of published, 
international guidelines and 
algorithms
 Opened access to CF Foundation 
Mental Health Listserv for 
Psychologists/Psychiatrists to all 
CF Providers
 Development and dissemination of 
Mental Health Toolbox
 Screening Tools free and available 
in all world languages
 IRB review and ethics
 Space and logistics in CF Clinics
 Developing plans to develop 
suicidal ideation
 Treating individuals in the 
moderate-severe range
 Training physicians to prescribe 
first-line antidepressants 
1 Each domain is defined and designated alphabetically (A, B, C, etc); within each domain, the survey questions and response provide data on the variables that 
facilitated implementation, as well as the barriers CF Centers were working to overcome. Dark and light shading demarcate each domain.
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B. Outer Setting
 Resources and training for 
MHC’s
 Evidence of elevated mental 
health symptoms for patients 
and parent caregivers
 Cosmopolitanism : CF 
Foundation resources & North 
American CF Conference 
 Peer pressure: Call to action 
from largest international CF 
medical conferences
 External policy and incentives: 
Screening guidelines adopted 
internationally 
 TIDES study documented 
patient/caregiver needs
 NACFC Plenary Presentation of 
TIDES data
 NACFC short courses
 Funding to attend NACFC
 Regional meetings
 CFF Funding of QI Initiatives over 
past 12 years
 Grant funding based on center 
size 
 Leadership involvement and 
support 
 Hiring/Identifying appropriate 
personnel 
 Stigma related to Mental Health 
screening
 Lack of mental health expertise 
on CF Team
 Resistance to adding new clinical 
practices 




o Type of center
o Size of center
 Training in Quality 
Improvement
 Annual surveys to gather data 
and feedback
 CF Center Director buy-in
 CF Foundation Leadership: 
Executive Vice President, Chief 
Medical Officer
 Multidisciplinary team meetings
 Patient/Family receptivity to 
screening 
 Annual surveys launched via CFF 
and Survey Monkey
 NACFC program content on 
Mental Health Screening and 
treatment
 MHC grants funded by CFF
 Implementing parent screening of 
depression/anxiety
 Ethical issues related to 
confidentiality and storage
 Lack of knowledge and training 
in Mental Health issues
D. Characteristics of individuals
 Years of experience in CF care
 Professional training and 
background 
 Mental health toolbox
 Development and dissemination of 
Welcome Packet
 Dissemination of materials via 
Mental Health listserv
 Open discussion forum on Mental 
Health listserv 
 Comfort with implementation of 
screening
 Little to no training in 
interventions
 Acceptability of the Screening 
program
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E. Process of Implementation
 MHC serves as champion of the 
program
 Involving and educating other 
stakeholders on the team 
 Informing and educating 
patients and caregivers about 
the new Mental Health 
Screening program 
 Plan for execution of annual 
screening 
 Training on guidelines and 
algorithms 
 Screening Tools were free
 Development of electronic version 
of screening tools
 Development and dissemination of 
electronic scoring programs for 
ease of interpretation
 Storage of screening data 
 Monthly mentoring program on 
complex cases
 Integrate  new processes for 
screening in year 1
 New personnel integrated into the 
team 
 Staff time 
 Lack of training in counseling 
strategies
 Identifying appropriate therapists 
in the community for outside 
referrals 
1Each domain in the CFIR Model is labeled alphabetically (A, B, etc) with alternating shading of dark and light. This column 
also provides definitions of the elements that make up this domain. Exemplars of both Facilitators and Barriers to 
implementation appear in the middle and far right columns, and were directly drawn from responses in the survey. 
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Table 2. Centre Characteristics (n=74)
Type of Centre n (%)
      Pediatric
      Adult




Number of patients in Program (range)
Number 12 years + (range)
13,771 (44 – 630)
8631 (5 – 492)
Profession n (%)
      Social Worker
      Psychologist




Length of time within CF team n (%)
     Newly appointed
     Less than 1 year
     1-5 years
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01Table 3. Screening process 
Preparedness
Somewhat to very prepared to perform patient screening
Somewhat to very prepared to perform caregiver screening
Somewhat to very prepared to provide patients with the results






Initiating the screening process was somewhat easy to very easy
Begun screening with PHQ9 & GAD7
Using recommended tools to screen caregivers*
Using the screening tools was somewhat easy to very easy
Scoring the screening tools was somewhat easy to very easy
Interpreting the screening tools was somewhat easy to very easy









Patient response to the screening was somewhat positive to very positive




Training, follow-up and referrals
Somewhat to adequately trained to counsel those scoring in mild range
Somewhat to adequately trained to provide evidence based psychological 
intervention to those scoring in moderate/severe range
Providing adequate follow-up was somewhat easy to very easy
Able to make patient referrals to MH clinicians in your hospital






*Answers for Pediatric Centers only
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Table 4. Successes of MH screening: Themes Identified in Open-Ended Responses
Greater awareness, detection and management of MH issues for CF Providers
 Adoption of the idea that mental health is critical to the overall health of the patient and 
their disease
 Improved understanding of how behavioral health impacts physical health
 Providing education about mental health to medical team (e.g., side effects of 
psychotropic medications)
 Development of a CF collaboration between clinical team and psychiatry and 
psychopharmacology
 Recognition of the value of this embedded service, both for providing higher provide 
quality care and improving patient outcomes and team satisfaction
 Objective data to identify and refer for treatment - people accessed services sooner
 Prevention and early identification before more serious mental health concerns arise 
 Picked up on a number of patients with depression and anxiety that had been missed 
previously
 Identification of those at risk for suicidality and ability to provide immediate referrals
 Identification of patients with benzodiazepine dependence.
 Tracking changes in mental health symptoms over time 
 Increased collaboration with community mental health providers
 Improvement in MH symptoms in those who are screened and treated
 CF team serving as model for mental health screening in other subspecialty clinics (e.g., 
asthma)
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Patients more able to discuss MH issues – destigmatizing MH concerns 
 Patients have been receptive to screening and view their physical and mental health as 
linked  
 Screening has helped normalize and destigmatize mental health issues even within CF 
team!
 Created a more open dialogue about mental health issues
 Patients who were resistant to mental health treatment in the past are now seeking care 
 Identification of depression and anxiety in patients who would not vocalize these 
symptoms
 More patients have opened-up about and expressed interest in mental health services
 Opportunity for patients, parents and providers to discuss the importance of behavioral 
health issues in CF care
 Increased patient awareness of support available to them in the CF center and community
Gratitude and support from families / patients for addressing MH
 Patients and families have embraced the screening process and often express “relief” that 
emotional health and well-being can be addressed 
 Families expressed gratitude that CF teams are acknowledging the challenges and stressors 
for caregivers 
 Offering patients and families options for treating anxiety and depression rather than 
learning to “live with it”. 
 Interest and acceptance of screening for caregivers; Parents feeling “heard”  
 Very appreciative that we are listening to them differently; integrating mental health into 
physical health visits
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Table 5. Barriers/Ethical issues of MH screening: Themes Identified in Content Analyses of Open-Ended Responses
‘Legal’ aspects of screening adult caregivers in a pediatric department and storage of 
caregiver data
 Dilemma that parent is not the “identified patient;” 
 Need to consider the ethical and legal/risk management implications of screening adult 
caregivers in a pediatric setting
 Confusion about where to record parent scores; inclusion in child’s EMR?
 Sharing information with team; how much to share?  
 CF parent community expressed concerns about storage of their MH data and privacy 
Difficulty with Logistics, Follow-up and Referrals 
 Patient perceptions indicated that clinics very busy and this might add time 
 Wanting some advanced notice about the onset of screening
 Lack of psychiatry support
 Challenges with logistics when someone is potentially suicidal; having adequate 
training and preparation for this
 Problems with referrals to mental health practitioners because of insurance barriers  
 Lack of clinical time to follow up for those with elevations in depression and anxiety
 Difficulty identifying providers in the community  
 Space to screen adolescent separately from parent
 Challenge of keeping adolescent screening data confidential and not sharing with 
parents 
 Patient's not following through with interventions and/or referrals made based on their 
scores
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